Logo

WORLDWIDE CLINICAL TRIALS 401(K) PLAN 401k Plan overview

Plan NameWORLDWIDE CLINICAL TRIALS 401(K) PLAN
Plan identification number 001

WORLDWIDE CLINICAL TRIALS 401(K) PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

WORLDWIDE CLINICAL TRIALS has sponsored the creation of one or more 401k plans.

Company Name:WORLDWIDE CLINICAL TRIALS
Employer identification number (EIN):261188036
NAIC Classification:541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan WORLDWIDE CLINICAL TRIALS 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012022-01-01JULIE WEAVER2023-03-10 JULIE WEAVER2023-03-10
0012021-01-01
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01MICHELE CYGAN MICHELE CYGAN2018-10-11
0012016-01-01KATHRYN LEWIS
0012016-01-01
0012016-01-01
0012015-01-01KATHRYN LEWIS
0012014-01-01KRISTIE STRAUB
0012013-01-01KRISTIE STRAUB
0012012-01-01KRISTIE STRAUB KRISTIE STRAUB2013-09-16
0012011-01-01KRISTIE STRAUB
0012009-01-01KRISTIE STRAUB

Plan Statistics for WORLDWIDE CLINICAL TRIALS 401(K) PLAN

401k plan membership statisitcs for WORLDWIDE CLINICAL TRIALS 401(K) PLAN

Measure Date Value
2021: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-011,111
Total number of active participants reported on line 7a of the Form 55002021-01-011,008
Number of retired or separated participants receiving benefits2021-01-010
Number of other retired or separated participants entitled to future benefits2021-01-010
Total of all active and inactive participants2021-01-011,008
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-010
Total participants2021-01-011,008
Number of participants with account balances2021-01-010
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-01105
2020: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-011,051
Total number of active participants reported on line 7a of the Form 55002020-01-01768
Number of retired or separated participants receiving benefits2020-01-011
Number of other retired or separated participants entitled to future benefits2020-01-01284
Total of all active and inactive participants2020-01-011,053
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-010
Total participants2020-01-011,053
Number of participants with account balances2020-01-01845
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-0197
2019: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-01897
Total number of active participants reported on line 7a of the Form 55002019-01-01804
Number of retired or separated participants receiving benefits2019-01-012
Number of other retired or separated participants entitled to future benefits2019-01-01258
Total of all active and inactive participants2019-01-011,064
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-010
Total participants2019-01-011,064
Number of participants with account balances2019-01-01809
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-0193
2018: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-01864
Total number of active participants reported on line 7a of the Form 55002018-01-01643
Number of retired or separated participants receiving benefits2018-01-011
Number of other retired or separated participants entitled to future benefits2018-01-01227
Total of all active and inactive participants2018-01-01871
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-010
Total participants2018-01-01871
Number of participants with account balances2018-01-01757
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-01121
2017: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-01847
Total number of active participants reported on line 7a of the Form 55002017-01-01654
Number of retired or separated participants receiving benefits2017-01-011
Number of other retired or separated participants entitled to future benefits2017-01-01211
Total of all active and inactive participants2017-01-01866
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-011
Total participants2017-01-01867
Number of participants with account balances2017-01-01780
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-01134
2016: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-01725
Total number of active participants reported on line 7a of the Form 55002016-01-01618
Number of retired or separated participants receiving benefits2016-01-010
Number of other retired or separated participants entitled to future benefits2016-01-01208
Total of all active and inactive participants2016-01-01826
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01826
Number of participants with account balances2016-01-01795
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-01161
2015: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-01756
Total number of active participants reported on line 7a of the Form 55002015-01-01529
Number of retired or separated participants receiving benefits2015-01-010
Number of other retired or separated participants entitled to future benefits2015-01-01185
Total of all active and inactive participants2015-01-01714
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01714
Number of participants with account balances2015-01-01682
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-01146
2014: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-01716
Total number of active participants reported on line 7a of the Form 55002014-01-01549
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-01184
Total of all active and inactive participants2014-01-01733
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01733
Number of participants with account balances2014-01-01693
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-01140
2013: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-01718
Total number of active participants reported on line 7a of the Form 55002013-01-01536
Number of retired or separated participants receiving benefits2013-01-010
Number of other retired or separated participants entitled to future benefits2013-01-01155
Total of all active and inactive participants2013-01-01691
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-010
Total participants2013-01-01691
Number of participants with account balances2013-01-01660
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-01108
2012: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01685
Total number of active participants reported on line 7a of the Form 55002012-01-01468
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-01250
Total of all active and inactive participants2012-01-01718
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-010
Total participants2012-01-01718
Number of participants with account balances2012-01-01679
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-01107
2011: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01645
Total number of active participants reported on line 7a of the Form 55002011-01-01420
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-01265
Total of all active and inactive participants2011-01-01685
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01685
Number of participants with account balances2011-01-01645
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-0188
2009: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01742
Total number of active participants reported on line 7a of the Form 55002009-01-01397
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-01155
Total of all active and inactive participants2009-01-01552
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01552
Number of participants with account balances2009-01-01422
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-01106

Financial Data on WORLDWIDE CLINICAL TRIALS 401(K) PLAN

Measure Date Value
2021 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total transfer of assets to this plan2021-12-31$0
Total transfer of assets from this plan2021-12-31$67,855,360
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$34,551
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$15,282,805
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$9,779,541
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$9,775,040
Expenses. Certain deemed distributions of participant loans2021-12-31$-91,674
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$9,578,182
Value of total assets at end of year2021-12-31$34,551
Value of total assets at beginning of year2021-12-31$62,352,096
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$96,175
Total interest from all sources2021-12-31$31,671
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$450,014
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$450,014
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$500,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$5,226,664
Participant contributions at beginning of year2021-12-31$679,475
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$2,395,894
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2021-12-31$34,551
Other income not declared elsewhere2021-12-31$158,205
Administrative expenses (other) incurred2021-12-31$96,175
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$5,503,264
Value of net assets at end of year (total assets less liabilities)2021-12-31$0
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$62,352,096
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$34,551
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$61,672,621
Interest on participant loans2021-12-31$31,671
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$5,064,733
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31Yes
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$1,955,624
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$9,775,040
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Disclaimer
Accountancy firm name2021-12-31KREISCHER MILLER
Accountancy firm EIN2021-12-31231980475
2020 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total transfer of assets to this plan2020-12-31$0
Total transfer of assets from this plan2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$18,908,696
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$5,913,795
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$5,739,568
Expenses. Certain deemed distributions of participant loans2020-12-31$74,221
Value of total corrective distributions2020-12-31$8,499
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$9,719,325
Value of total assets at end of year2020-12-31$62,352,096
Value of total assets at beginning of year2020-12-31$49,357,195
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$91,507
Total interest from all sources2020-12-31$28,180
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$1,948,598
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$1,948,598
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$500,000
If this is an individual account plan, was there a blackout period2020-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$4,984,249
Participant contributions at end of year2020-12-31$679,475
Participant contributions at beginning of year2020-12-31$511,450
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$2,802,016
Other income not declared elsewhere2020-12-31$103,717
Administrative expenses (other) incurred2020-12-31$91,507
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$12,994,901
Value of net assets at end of year (total assets less liabilities)2020-12-31$62,352,096
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$49,357,195
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$61,672,621
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$48,845,745
Interest on participant loans2020-12-31$28,180
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$7,108,876
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31Yes
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$1,933,060
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$5,739,568
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Disclaimer
Accountancy firm name2020-12-31KREISCHER MILLER
Accountancy firm EIN2020-12-31231980475
2019 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total transfer of assets to this plan2019-12-31$0
Total transfer of assets to this plan2019-12-31$0
Total transfer of assets from this plan2019-12-31$0
Total transfer of assets from this plan2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$16,004,944
Total loss/gain on sale of assets2019-12-31$0
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$2,658,048
Total of all expenses incurred2019-12-31$2,658,048
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$2,514,185
Expenses. Certain deemed distributions of participant loans2019-12-31$61,090
Expenses. Certain deemed distributions of participant loans2019-12-31$61,090
Value of total corrective distributions2019-12-31$7,350
Value of total corrective distributions2019-12-31$7,350
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$7,396,031
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$7,396,031
Value of total assets at end of year2019-12-31$49,357,195
Value of total assets at end of year2019-12-31$49,357,195
Value of total assets at beginning of year2019-12-31$36,010,299
Value of total assets at beginning of year2019-12-31$36,010,299
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$75,423
Total interest from all sources2019-12-31$30,560
Total interest from all sources2019-12-31$30,560
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$1,832,100
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$1,832,100
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$1,832,100
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$1,832,100
Was this plan covered by a fidelity bond2019-12-31Yes
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$4,460,879
Contributions received from participants2019-12-31$4,460,879
Participant contributions at end of year2019-12-31$511,450
Participant contributions at end of year2019-12-31$511,450
Participant contributions at beginning of year2019-12-31$543,206
Participant contributions at beginning of year2019-12-31$543,206
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$1,033,047
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$1,033,047
Other income not declared elsewhere2019-12-31$83,901
Other income not declared elsewhere2019-12-31$83,901
Administrative expenses (other) incurred2019-12-31$75,423
Administrative expenses (other) incurred2019-12-31$75,423
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$13,346,896
Value of net income/loss2019-12-31$13,346,896
Value of net assets at end of year (total assets less liabilities)2019-12-31$49,357,195
Value of net assets at end of year (total assets less liabilities)2019-12-31$49,357,195
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$36,010,299
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$36,010,299
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$48,845,745
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$48,845,745
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$35,467,093
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$35,467,093
Interest on participant loans2019-12-31$30,560
Interest on participant loans2019-12-31$30,560
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$6,662,352
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$6,662,352
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$1,902,105
Contributions received in cash from employer2019-12-31$1,902,105
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$2,514,185
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$2,514,185
Did the plan have assets held for investment2019-12-31Yes
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31KREISCHER MILLER
Accountancy firm EIN2019-12-31231980475
Accountancy firm EIN2019-12-31231980475
2018 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total transfer of assets to this plan2018-12-31$0
Total transfer of assets from this plan2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$4,024,985
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$4,292,333
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$4,276,395
Expenses. Certain deemed distributions of participant loans2018-12-31$8,114
Value of total corrective distributions2018-12-31$172
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$6,563,273
Value of total assets at end of year2018-12-31$36,010,299
Value of total assets at beginning of year2018-12-31$36,277,647
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$7,652
Total interest from all sources2018-12-31$20,846
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$2,330,867
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$2,330,867
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$500,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$4,187,066
Participant contributions at end of year2018-12-31$543,206
Participant contributions at beginning of year2018-12-31$432,421
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$558,386
Other income not declared elsewhere2018-12-31$5,048
Administrative expenses (other) incurred2018-12-31$7,652
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-267,348
Value of net assets at end of year (total assets less liabilities)2018-12-31$36,010,299
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$36,277,647
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$35,467,093
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$35,845,226
Interest on participant loans2018-12-31$20,846
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-4,895,049
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$1,817,821
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$4,276,395
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31KREISCHER MILLER
Accountancy firm EIN2018-12-31231980475
2017 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total transfer of assets to this plan2017-12-31$0
Total transfer of assets from this plan2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$10,336,710
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$3,227,902
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$3,176,865
Expenses. Certain deemed distributions of participant loans2017-12-31$3,164
Value of total corrective distributions2017-12-31$29,077
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$5,402,741
Value of total assets at end of year2017-12-31$36,277,647
Value of total assets at beginning of year2017-12-31$29,168,839
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$18,796
Total interest from all sources2017-12-31$18,922
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$1,412,830
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$1,412,830
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$500,000
If this is an individual account plan, was there a blackout period2017-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$3,740,542
Participant contributions at end of year2017-12-31$432,421
Participant contributions at beginning of year2017-12-31$487,414
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$31,235
Other income not declared elsewhere2017-12-31$4,997
Administrative expenses (other) incurred2017-12-31$18,796
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$7,108,808
Value of net assets at end of year (total assets less liabilities)2017-12-31$36,277,647
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$29,168,839
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$35,845,226
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$28,681,425
Interest on participant loans2017-12-31$18,922
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$3,497,220
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$1,630,964
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$3,176,865
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31KREISCHER MILLER
Accountancy firm EIN2017-12-31231980475
2016 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total transfer of assets to this plan2016-12-31$0
Total transfer of assets from this plan2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$7,444,911
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$7,098,111
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$7,015,591
Expenses. Certain deemed distributions of participant loans2016-12-31$3,438
Value of total corrective distributions2016-12-31$70,990
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$5,219,953
Value of total assets at end of year2016-12-31$29,168,839
Value of total assets at beginning of year2016-12-31$28,822,039
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$8,092
Total interest from all sources2016-12-31$17,446
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$910,919
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$910,919
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$500,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$3,397,752
Participant contributions at end of year2016-12-31$487,414
Participant contributions at beginning of year2016-12-31$418,601
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$364,451
Other income not declared elsewhere2016-12-31$8,177
Administrative expenses (other) incurred2016-12-31$8,092
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$346,800
Value of net assets at end of year (total assets less liabilities)2016-12-31$29,168,839
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$28,822,039
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$28,681,425
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$28,403,438
Interest on participant loans2016-12-31$17,446
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$1,288,416
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$1,457,750
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$7,015,591
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2016-12-31742900215
2015 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total transfer of assets to this plan2015-12-31$0
Total transfer of assets from this plan2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$5,281,698
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$3,167,951
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$3,053,066
Expenses. Certain deemed distributions of participant loans2015-12-31$5,655
Value of total corrective distributions2015-12-31$97,223
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$5,671,034
Value of total assets at end of year2015-12-31$28,822,039
Value of total assets at beginning of year2015-12-31$26,708,292
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$12,007
Total interest from all sources2015-12-31$15,343
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$1,742,282
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$1,742,282
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$500,000
If this is an individual account plan, was there a blackout period2015-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$2,997,160
Participant contributions at end of year2015-12-31$418,601
Participant contributions at beginning of year2015-12-31$357,421
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$1,296,991
Other income not declared elsewhere2015-12-31$7,671
Administrative expenses (other) incurred2015-12-31$12,007
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$2,113,747
Value of net assets at end of year (total assets less liabilities)2015-12-31$28,822,039
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$26,708,292
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$28,403,438
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$26,350,871
Interest on participant loans2015-12-31$15,343
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-2,154,632
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$1,376,883
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$3,053,066
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2015-12-31742900215
2014 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total transfer of assets to this plan2014-12-31$0
Total transfer of assets from this plan2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$5,808,367
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$2,441,742
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$2,373,453
Expenses. Certain deemed distributions of participant loans2014-12-31$173
Value of total corrective distributions2014-12-31$55,795
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$4,622,895
Value of total assets at end of year2014-12-31$26,708,292
Value of total assets at beginning of year2014-12-31$23,341,667
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$12,321
Total interest from all sources2014-12-31$16,537
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$1,762,469
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$1,762,469
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$500,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$2,610,948
Participant contributions at end of year2014-12-31$357,421
Participant contributions at beginning of year2014-12-31$380,009
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$995,914
Other income not declared elsewhere2014-12-31$5,881
Administrative expenses (other) incurred2014-12-31$12,321
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$3,366,625
Value of net assets at end of year (total assets less liabilities)2014-12-31$26,708,292
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$23,341,667
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$26,350,871
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$22,961,658
Interest on participant loans2014-12-31$16,537
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$-599,415
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$1,016,033
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$2,373,453
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2014-12-31742900215
2013 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$6,938,885
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$1,398,807
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$1,386,898
Expenses. Certain deemed distributions of participant loans2013-12-31$1,675
Value of total corrective distributions2013-12-31$309
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$3,673,422
Value of total assets at end of year2013-12-31$23,341,667
Value of total assets at beginning of year2013-12-31$17,801,589
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$9,925
Total interest from all sources2013-12-31$18,207
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$1,133,137
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$1,133,137
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$500,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$2,305,897
Participant contributions at end of year2013-12-31$380,009
Participant contributions at beginning of year2013-12-31$353,181
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$346,533
Other income not declared elsewhere2013-12-31$3,584
Administrative expenses (other) incurred2013-12-31$9,925
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$5,540,078
Value of net assets at end of year (total assets less liabilities)2013-12-31$23,341,667
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$17,801,589
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$22,961,658
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$17,448,408
Interest on participant loans2013-12-31$18,207
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$2,110,535
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$1,020,992
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$1,386,898
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2013-12-31742900215
2012 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$5,010,429
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$2,425,456
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$2,341,009
Expenses. Certain deemed distributions of participant loans2012-12-31$4,264
Value of total corrective distributions2012-12-31$61,635
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$3,324,377
Value of total assets at end of year2012-12-31$17,801,589
Value of total assets at beginning of year2012-12-31$15,216,616
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$18,548
Total interest from all sources2012-12-31$17,783
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$567,456
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$567,456
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$500,000
If this is an individual account plan, was there a blackout period2012-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2012-12-31$0
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$2,193,078
Participant contributions at end of year2012-12-31$353,181
Participant contributions at beginning of year2012-12-31$343,316
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$136,930
Administrative expenses (other) incurred2012-12-31$18,548
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$2,584,973
Value of net assets at end of year (total assets less liabilities)2012-12-31$17,801,589
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$15,216,616
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$17,448,408
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$14,873,300
Interest on participant loans2012-12-31$17,783
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$1,100,813
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$994,369
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$2,341,009
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2012-12-31742900215
2011 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total income from all sources (including contributions)2011-12-31$2,116,662
Total loss/gain on sale of assets2011-12-31$0
Total of all expenses incurred2011-12-31$1,345,460
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$1,253,017
Expenses. Certain deemed distributions of participant loans2011-12-31$21,218
Value of total corrective distributions2011-12-31$55,316
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$2,696,334
Value of total assets at end of year2011-12-31$15,216,616
Value of total assets at beginning of year2011-12-31$14,445,414
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$15,909
Total interest from all sources2011-12-31$17,745
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$375,389
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$375,389
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$500,000
If this is an individual account plan, was there a blackout period2011-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2011-12-31$0
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$1,824,185
Participant contributions at end of year2011-12-31$343,316
Participant contributions at beginning of year2011-12-31$345,494
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$14,923
Administrative expenses (other) incurred2011-12-31$15,909
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$771,202
Value of net assets at end of year (total assets less liabilities)2011-12-31$15,216,616
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$14,445,414
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$14,873,300
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$14,099,920
Interest on participant loans2011-12-31$17,745
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-972,806
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$857,226
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$1,253,017
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2011-12-31742900215
2010 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total income from all sources (including contributions)2010-12-31$4,082,269
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$1,010,847
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$967,987
Expenses. Certain deemed distributions of participant loans2010-12-31$130
Value of total corrective distributions2010-12-31$28,873
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$2,751,850
Value of total assets at end of year2010-12-31$14,445,414
Value of total assets at beginning of year2010-12-31$11,373,992
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$13,857
Total interest from all sources2010-12-31$21,619
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$190,130
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$190,130
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$500,000
If this is an individual account plan, was there a blackout period2010-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2010-12-31$0
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$1,761,771
Participant contributions at end of year2010-12-31$345,494
Participant contributions at beginning of year2010-12-31$343,576
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$178,641
Administrative expenses (other) incurred2010-12-31$13,857
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$3,071,422
Value of net assets at end of year (total assets less liabilities)2010-12-31$14,445,414
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$11,373,992
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$14,099,920
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$11,030,416
Interest on participant loans2010-12-31$21,619
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$1,118,670
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$811,438
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$967,987
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31MAXWELL LOCKE & RITTER LLP
Accountancy firm EIN2010-12-31742900215
2009 : WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2009-12-31$0

Form 5500 Responses for WORLDWIDE CLINICAL TRIALS 401(K) PLAN

2021: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes
2020: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement - TrustYes
2019: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2018: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement - TrustYes
2017: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedYes
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2009: WORLDWIDE CLINICAL TRIALS 401(K) PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S1